A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DBMC / donor bone marrow cells

[Related PubMed/MEDLINE]
Total Number of Papers: 23
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DBMC  (>> Co-occurring Abbreviation)
Long Form:   donor bone marrow cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2013 Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival. LURD
2012 Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion. IFN-gamma, IL, PHA
2010 Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays. haplo controls, IS
2008 Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model. GVHD, NOD, PBL, SCID
2005 Campath-1H does not alter bone marrow cell regulatory function. BMC, Treg
2005 The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. ---
2004 [Effects of donor-specific bone marrow cell infusion on chimerism and acute rejection in kidney transplantation]. ---
2003 A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses. CML, m-CML, vDBMC-L
2002 Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. CML, GVHD, MLR
10  2001 Six-year clinical effect of donor bone marrow infusions in renal transplant patients. CAD
11  1999 Analysis of post-transplant immune status in recipients of liver/bone marrow allografts. CML, MLC, PBL, SI
12  1999 In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation. CML, MLC, MPA, PBL
13  1999 Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells. PLT, PTLD
14  1999 Thrombocytopenia after liver transplantation. CMV, DB, OLT, TB, WBC
15  1998 Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. CML, MLC, MPA
16  1998 Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. LRD, PCR-Flow
17  1997 High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. ---
18  1997 Use of allogeneic bone marrow labeled with neomycin resistance gene to examine bone marrow-derived chimerism in experimental organ transplantation. PCR-SSP
19  1996 Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. ---
20  1996 Status of liver and gastrointestinal transplantation at the University of Miami. alpha-IFN
21  1995 The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. ADCC
22  1994 Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice. ---
23  1992 The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. PT-TLI, rATG